About this trial
Muscle dysfunction in intensive care units is associated with significant morbidity and mortality. During septic shock, there is an increased catabolism and systemic inflammation resulting in quantitative and qualitative muscle impairment. In the intensive care setting, quantitative and qualitative assessment of muscle function is challenging due to critical care environments (general anesthesia, altered consciousness, etc.). CT scan measurement at the 3rd lumbar level has been proposed to evaluate muscle function. Recent retrospective studies have highlighted increased mortality among patients with muscle mass impairment and/or decreased muscle density.
Eligibility criteria
Qualifiers
Patients who underwent a non-contrast CT scan within 48 hours prior to admission and up to 24 hours after admission to intensive care
Patients affiliated with or eligible for social security
Disqualifiers
Patients with a neuromuscular disease prior to admission to intensive care.
Pregnant women
Patients under guardianship and/or conservatorship
Refusal of consent.
Trial design
Treatments tested in this trial
- Evaluation of muscle dysfunction in intensive care units for septic schock patients